Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Thrombodyne Inc
Profile last edited on: 3/16/20      CAGE: 4P4Z4      UEI: RMCNNVCMSXB1

Business Identifier: Thrombosis and thromboresistance testing
Year Founded
2007
First Award
2019
Latest Award
2020
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

825 N 300 W STE C250
Salt Lake City, UT 84103
   (801) 318-4427
   N/A
   www.thrombodyne.com
Location: Single
Congr. District: 02
County: Salt Lake

Public Profile

Thrombodyne is a medical research and development entity dedicated to advancing the safety and efficacy of blood-contacting medical devices, both through performing third-party testing of devices as well as designing new medical systems. Specialists at Thrombodyne continue to refine and adapt the latest techniques of thrombosis and thromboresistance testing to keep pace with the rapidly advancing field of medical devices.

Extent of SBIR involvement

User Avatar
Phase I Awards
2
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$674,449
Phase II Dollars
$0
Total Awarded
$674,449

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2020 1 NIH $388,161
Project Title: Antimicrobial Technology To Actively Mitigate Hydrocephalus Shunt Infections Long Term
2019 1 NIH $286,288
Project Title: Antimicrobial Technology to Actively Mitigate Ear Tube Infections Long Term

Key People / Management

  Burns Gregory Lee

  Marion Walker

Company News

There are no news available.